Daily Octreotide Doses Before and After 90Y-SMT 487 Therapy
Patient no. | Octreotide dose (mg) | Clinical response | ||
---|---|---|---|---|
Before therapy | After therapy | |||
1 | 1,200 | 100 | S | |
2 | 300 | 900 | I | |
3 | 0 | 0 | I | |
4 | 300 | 200 | I | |
5 | 100 | 0 | P | |
6 | 300 | 150 | I | |
7 | 600 | 600 | I | |
8 | 1,200 | 1,200 | I | |
9 | 600 | 600 | S | |
10 | 600 | 300 | I | |
11 | 300 | 0 | I | |
12 | 6,000 | 2,100 | S | |
13 | 600 | 450 | I | |
14 | 600 | 100 | I | |
15 | 600 | 600 | S | |
16 | 1,600 | 1,350 | I | |
17 | 1,500 | 1,500 | P | |
18 | 600 | 300 | I | |
19 | 400 | 300 | I | |
20 | 600–900 | 600 | I | |
21 | 800 | 600 | I |
S = stable; I = improved; P = progression.